"Trojan horse" strategy enters phase 1 trial for breast cancer.
Larkin
Marilynn
M
D001943:Breast Neoplasms / Q000378:metabolism / Q000532:radiotherapy*; D017321:Clinical Trials, Phase I as Topic; D016503:Drug Delivery Systems / Q000379:methods*; D004815:Epidermal Growth Factor / Q000008:administration & dosage* / Q000378:metabolism; D005260:Female; D006801:Humans; D007205:Indium Radioisotopes / Q000008:administration & dosage*; D019275:Radiopharmaceuticals / Q000008:administration & dosage*
D007205:Indium Radioisotopes; D019275:Radiopharmaceuticals; D004815:Epidermal Growth Factor